Conference
Quantitative risk-benefit analysis of alosetron in irritiable bowel syndrome: A patient-level meta-cohort analysis
Authors
Lynd LD; Colley L; Najafzedeh M; Sculpher MJ; Willan AR; Johnson RF; Ozdemir S
Volume
16
Pagination
pp. S183-S183
Publisher
WILEY
Publication Date
August 1, 2007
Conference proceedings
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569